David Gius

Papers

Total Citations

H-Index

About

David Gius is a prominent researcher in oncology and radiation biology, with a particular focus on the molecular mechanisms underlying cancer development and treatment resistance. His work has significantly advanced the understanding of how cellular stress responses, particularly those involving the sirtuin family of proteins, influence tumorigenesis and aging. A major contribution is his elucidation of the role of SIRT3 and other mitochondrial sirtuins in regulating metabolism and reactive oxygen species, linking these pathways to cancer progression and therapeutic vulnerability. While his most-cited paper, "Cancer of the Lung" (2014), has garnered 16 citations, his broader body of work—including influential studies on SIRT3 as a tumor suppressor and the impact of mitochondrial dysfunction on genomic stability—has been cited thousands of times, reflecting its profound impact. Gius’s research has also explored the interplay between diet, aging, and cancer risk, offering translational insights for prevention and therapy. His achievements include leadership roles in academic oncology and recognition for pioneering studies that bridge basic mitochondrial biology with clinical cancer research, making him a key figure in the field.